| 0 | 💬 0 |
Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-03-14 | #prophylaxis #safety #hiv |